CDC raises EBITDA guidance by 25% for second half
Chinese software and new media company CDC Corp. (Nasdaq:CHINA) said this morning that it is raising its earnings before interest taxes depreciation and amortization (EBITDA) guidance by 25% for the second half of 2008.
The company expects adjusted EBITDA to be in the range of approximately $10 million to $12.5 million, compared with $1.4 million for the same period in 2007.
Shares edged up 0.92%, or $0.02, to $2.19 at 10:05 a.m. ET. For detailed price information and news stories on CDC, click CHINA.
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
